VANGUARD GROUP INC - EFFECTOR THERAPEUTICS INC ownership

EFFECTOR THERAPEUTICS INC's ticker is and the CUSIP is 28202V108. A total of 19 filers reported holding EFFECTOR THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 2.8%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of EFFECTOR THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$242,375
-28.1%
404,026
-0.5%
0.00%
Q2 2023$336,994
+135.4%
405,9190.0%0.00%
Q1 2023$143,168
-22.0%
405,919
-5.4%
0.00%
Q4 2022$183,459
-25.1%
429,0430.0%0.00%
Q3 2022$245,000
-66.6%
429,043
-17.0%
0.00%
Q2 2022$734,000
-64.6%
516,7980.0%0.00%
Q1 2022$2,072,000
-51.5%
516,798
+0.1%
0.00%
Q4 2021$4,274,000516,1640.00%
Other shareholders
EFFECTOR THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,822,114$4,025,0472.06%
Column Group LLC 4,026,224$2,415,3321.60%
OUP Management Co., LLC 1,025,697$615,3161.38%
SECTORAL ASSET MANAGEMENT INC 2,382,644$1,429,3480.28%
Carlyle Group Inc. 4,822,114$2,868,6760.12%
Sea Otter Advisors LLC 263,942$158,3390.09%
Parallel Advisors, LLC 1,693,559$1,015,9660.03%
Sonora Investment Management Group, LLC 125,000$74,9880.01%
Wescott Financial Advisory Group, LLC 30,556$18,3310.00%
Oasis Management Co Ltd. 100,000$59,9900.00%
View complete list of EFFECTOR THERAPEUTICS INC shareholders